Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Wubetu Yihunie, Bekalu Kebede, Bantayehu Addis Tegegne, Melese Getachew, Dehnnet Abebe, Yibeltal Aschale, Habtamu Belew & Bereket Bahiru. (2023) Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults. Clinical Pharmacology: Advances and Applications 15, pages 21-32.
Read now
Read now
Tomáš Hanke. (2014) Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines. Expert Opinion on Biological Therapy 14:5, pages 601-616.
Read now
Read now
Jiří Beran, Lenka Hobzova, Veronika Wertzova, Sherine Kuriyakose, Maarten Leyssen, Murielle Surquin & Sophie Houard. (2010) Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults. Human Vaccines 6:7, pages 578-584.
Read now
Read now
Katarina Radošević, Ariane Rodriguez, Angelique Lemckert & Jaap Goudsmit. (2009) Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Review of Vaccines 8:5, pages 577-592.
Read now
Read now
Blaise Genton. (2008) Malaria vaccines: a toy for travelers or a tool for eradication?. Expert Review of Vaccines 7:5, pages 597-611.
Read now
Read now
Denise L Doolan & V Ann Stewart. (2007) Status of malaria vaccine R&D in 2007. Expert Review of Vaccines 6:6, pages 903-905.
Read now
Read now
Articles from other publishers (16)
Aroosa Younis Nadeem, Adeeb Shehzad, Salman Ul Islam, Ebtesam A. Al-Suhaimi & Young Sup Lee. (2022) Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines 10:5, pages 713.
Crossref
Crossref
Eleanor M Riley & V Ann Stewart. (2013) Immune mechanisms in malaria: new insights in vaccine development. Nature Medicine 19:2, pages 168-178.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2013. Clinical Immunology. Clinical Immunology
1095
1121
.
Kiren Ubhi & Eliezer Masliah. (2011) Recent advances in the development of immunotherapies for tauopathies. Experimental Neurology 230:2, pages 157-161.
Crossref
Crossref
Murielle Surquin, Christian L. Tielemans, Imre Kulcsár, Miroslav Ryba, Péter Vörös, Olivier Mat, Serge Treille, Michel Dhaene, Jean-Claude Stolear, Sherine O. Kuriyakose, Maarten X. Leyssen & Sophie A. Houard. (2010) Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine. Kidney International 77:3, pages 247-255.
Crossref
Crossref
Amadu Jalloh, Muctarr Jalloh & Hiroyuki Matsuoka. (2009) T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution?. Malaria Journal 8:1.
Crossref
Crossref
W. R. BALLOU. (2009) The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunology 31:9, pages 492-500.
Crossref
Crossref
George Jiang, Meng Shi, Solomon Conteh, Nancy Richie, Glenna Banania, Harini Geneshan, Anais Valencia, Priti Singh, Joao Aguiar, Keith Limbach, Kurt I. Kamrud, Jonathan Rayner, Jonathan Smith, Joseph T. Bruder, C. Richter King, Takafumi Tsuboi, Satoru Takeo, Yaeta Endo, Denise L. Doolan, Thomas L. Richie & Walter R. Weiss. (2009) Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies. PLoS ONE 4:8, pages e6559.
Crossref
Crossref
Steven G. ReedRhea N. ColerWilfried DalemansEsterlina V. Tan, Eduardo C. DeLa Cruz, Randall J. Basaraba, Ian M. Orme, Yasir A. W. SkeikyMark R. AldersonKaren D. CowgillJean-Paul PrieelsRodolfo M. Abalos, Marie-Claude DuboisJoe CohenPascal MettensYves Lobet. (2009) Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proceedings of the National Academy of Sciences 106:7, pages 2301-2306.
Crossref
Crossref
Wan-Shoo Cheong, Jessica Reiseger, Stephen John Turner, Richard Boyd & Hans-Jürgen Netter. (2009) Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope. Antiviral Research 81:2, pages 113-122.
Crossref
Crossref
Robert Ménard, Volker Heussler, Masao Yuda & Victor Nussenzweig. (2008) Plasmodium pre-erythrocytic stages: what’s new?. Trends in Parasitology 24:12, pages 564-569.
Crossref
Crossref
Edmond J. Remarque, Bart W. Faber, Clemens H.M. Kocken & Alan W. Thomas. (2008) Apical membrane antigen 1: a malaria vaccine candidate in review. Trends in Parasitology 24:2, pages 74-84.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2008. Clinical Immunology. Clinical Immunology
1353
1382
.
Kai Matuschewski & Ann‐Kristin Mueller. (2007) Vaccines against malaria – an update. The FEBS Journal 274:18, pages 4680-4687.
Crossref
Crossref
Pierre Druilhe & John W Barnwell. (2007) Pre-erythrocytic stage malaria vaccines: time for a change in path. Current Opinion in Microbiology 10:4, pages 371-378.
Crossref
Crossref
Bernard N Kanoi & Thomas G Egwang. (2007) New concepts in vaccine development in malaria. Current Opinion in Infectious Diseases 20:3, pages 311-316.
Crossref
Crossref